Literature DB >> 16822458

Dyskeratosis congenita.

Tom Vulliamy1, Inderjeet Dokal.   

Abstract

Dyskeratosis congenita (DC) is a rare inherited multi-system disorder. Although DC is classically characterized by mucocutaneous features, the vast majority of patients develop hematologic abnormalities, and in its occult form the disease can present as aplastic anemia. The gene responsible for the X-linked form of the disease encodes a protein involved in ribosome biogenesis and in stabilizing the telomerase complex, while the autosomal dominant form is caused by mutations in the core RNA component of telomerase. It has been suggested that DC is primarily a disease of defective telomere maintenance. Premature shortening of telomeres resulting in a limited proliferative potential of stem cells would explain the pathology observed in DC, as the affected tissues are those that require constant renewal.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16822458     DOI: 10.1053/j.seminhematol.2006.04.001

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


  38 in total

1.  Dyskeratosis congenita with malignant transformation.

Authors:  Jay Gopal Ray; Niharika Swain; Ranjan Ghosh; Swetag Pattanayak Mohanty
Journal:  BMJ Case Rep       Date:  2011-01-11

Review 2.  Anemia of Central Origin.

Authors:  Kazusa Ishii; Neal S Young
Journal:  Semin Hematol       Date:  2015-07-09       Impact factor: 3.851

Review 3.  Neonatal manifestations of inherited bone marrow failure syndromes.

Authors:  Payal P Khincha; Sharon A Savage
Journal:  Semin Fetal Neonatal Med       Date:  2015-12-24       Impact factor: 3.926

4.  Similar telomere attrition rates in androgen-treated and untreated patients with dyskeratosis congenita.

Authors:  Payal P Khincha; Alison A Bertuch; Shahinaz M Gadalla; Neelam Giri; Blanche P Alter; Sharon A Savage
Journal:  Blood Adv       Date:  2018-06-12

5.  Genetic Variations in Telomere Maintenance, with Implications on Tissue Renewal Capacity and Chronic Disease Pathologies.

Authors:  M A Trudeau; J M Y Wong
Journal:  Curr Pharmacogenomics Person Med       Date:  2010-03-01

6.  Frequency and natural history of inherited bone marrow failure syndromes: the Israeli Inherited Bone Marrow Failure Registry.

Authors:  Hannah Tamary; Daniella Nishri; Joanne Yacobovich; Rama Zilber; Orly Dgany; Tanya Krasnov; Shraga Aviner; Polina Stepensky; Shoshana Ravel-Vilk; Menachem Bitan; Chaim Kaplinsky; Ayelet Ben Barak; Ronit Elhasid; Joseph Kapelusnik; Ariel Koren; Carina Levin; Dina Attias; Ruth Laor; Isaac Yaniv; Philip S Rosenberg; Blanche P Alter
Journal:  Haematologica       Date:  2010-04-30       Impact factor: 9.941

7.  Response to androgen therapy in patients with dyskeratosis congenita.

Authors:  Payal P Khincha; Ingrid M Wentzensen; Neelam Giri; Blanche P Alter; Sharon A Savage
Journal:  Br J Haematol       Date:  2014-02-12       Impact factor: 6.998

8.  Mutations in the SBDS gene in acquired aplastic anemia.

Authors:  Rodrigo T Calado; Solomon A Graf; Keisha L Wilkerson; Sachiko Kajigaya; Philip J Ancliff; Yigal Dror; Stephen J Chanock; Peter M Lansdorp; Neal S Young
Journal:  Blood       Date:  2007-05-03       Impact factor: 22.113

9.  Defective proliferative capacity and accelerated telomeric loss of hematopoietic progenitor cells in rheumatoid arthritis.

Authors:  Inés Colmegna; Alejandro Diaz-Borjon; Hiroshi Fujii; Linda Schaefer; Jörg J Goronzy; Cornelia M Weyand
Journal:  Arthritis Rheum       Date:  2008-04

Review 10.  Cancer in dyskeratosis congenita.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; Philip S Rosenberg
Journal:  Blood       Date:  2009-03-12       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.